Cargando…
Fibroblast Growth Factor 23 and Osteoporosis: Evidence from Bench to Bedside
Osteoporosis is a chronic debilitating disease caused by imbalanced bone remodeling processes that impair the structural integrity of bone. Over the last ten years, the association between fibroblast growth factor 23 (FGF23) and osteoporosis has been studied in both pre-clinical and clinical investi...
Autores principales: | Sirikul, Wachiranun, Siri-Angkul, Natthaphat, Chattipakorn, Nipon, Chattipakorn, Siriporn C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909928/ https://www.ncbi.nlm.nih.gov/pubmed/35269640 http://dx.doi.org/10.3390/ijms23052500 |
Ejemplares similares
-
Cellular Electrophysiology of Iron-Overloaded Cardiomyocytes
por: Siri-Angkul, Natthaphat, et al.
Publicado: (2018) -
Gasdermin D-mediated pyroptosis in myocardial ischemia and reperfusion injury: Cumulative evidence for future cardioprotective strategies
por: Yanpiset, Panat, et al.
Publicado: (2023) -
Targeting necroptosis as therapeutic potential in chronic myocardial infarction
por: Piamsiri, Chanon, et al.
Publicado: (2021) -
Effectiveness of high cardiorespiratory fitness in cardiometabolic protection in prediabetic rats
por: Thonusin, Chanisa, et al.
Publicado: (2022) -
Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients
por: Wijarnpreecha, Karn, et al.
Publicado: (2015)